| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/24/2008 | WO2008156160A1 Composition for transdermal or transmucosal administration |
| 12/24/2008 | WO2008156153A1 Preventive/remedy for cancer |
| 12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 12/24/2008 | WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008156092A1 Azolylmethylidenehydrazine derivative and use thereof |
| 12/24/2008 | WO2008156012A1 CANCER REMEDY CONTAINING MORTALIN siRNA |
| 12/24/2008 | WO2008155999A1 Gabaergic neuron activator |
| 12/24/2008 | WO2008155998A1 Antianxiety/antidepressant agent |
| 12/24/2008 | WO2008155920A1 Drug having effect of promoting hepatocyte growth |
| 12/24/2008 | WO2008155818A1 Preventive or therapeutic agent for frequent urination and urinary incontinence |
| 12/24/2008 | WO2008155651A2 Inositol for induction of ovulation |
| 12/24/2008 | WO2008155620A1 Dosage form containing dispersible matrix of sustained release granules |
| 12/24/2008 | WO2008155594A2 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof |
| 12/24/2008 | WO2008155588A1 Sulfonyl-quinoline derivatives |
| 12/24/2008 | WO2008155573A1 Cinnoline compounds for use in the treatment of schizophrenia |
| 12/24/2008 | WO2008155535A1 Use of halogenated salicylanilides for the treatment of acne |
| 12/24/2008 | WO2008155533A2 Phenothiazine compounds for treating mild cognitive impairment |
| 12/24/2008 | WO2008155520A2 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain |
| 12/24/2008 | WO2008155468A1 Activators and therapeutic applications thereof |
| 12/24/2008 | WO2008155441A1 Activators and therapeutic applications thereof |
| 12/24/2008 | WO2008155421A2 Indolin-2-ones and aza-indolin-2-ones |
| 12/24/2008 | WO2008155405A1 Crystalline solid forms |
| 12/24/2008 | WO2008155393A1 Use of oxygenated heterocycles chosen from xanthones and biflavonoids for the preparation of a composition intended to act as an anti-coccidial agent |
| 12/24/2008 | WO2008155390A2 Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases. |
| 12/24/2008 | WO2008155378A1 Polymorphic and hydrate forms, salts and process for preparing 6-{difluoro[6-(1-methyl-1h-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline |
| 12/24/2008 | WO2008155357A2 Use of dopamine stabilizers |
| 12/24/2008 | WO2008155351A1 Homocysteine analogues |
| 12/24/2008 | WO2008155335A1 Protease activated receptor-1 antagonists for the treatment of atrial fibrillation |
| 12/24/2008 | WO2008155141A2 Novel facultative catonic sterols |
| 12/24/2008 | WO2008155140A1 Alkynylpyrimidines as tie2 kinase inhibitors |
| 12/24/2008 | WO2008155132A1 Spiro [piperidine-4, 4' -thieno [3, 2-c] pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis |
| 12/24/2008 | WO2008155081A2 Substituted aromatic heterocyclic compounds as fungicides |
| 12/24/2008 | WO2008155075A2 Shampoo composition having improved care properties |
| 12/24/2008 | WO2008155074A2 Method for preparing finely divided emulsions |
| 12/24/2008 | WO2008155073A2 Shampoo composition having improved care properties |
| 12/24/2008 | WO2008155069A2 Substituted oxazolidinones and use thereof |
| 12/24/2008 | WO2008155061A2 Cosmetic preparations containing hydrocarbons |
| 12/24/2008 | WO2008155060A2 Hydrocarbon mixtures and use thereof |
| 12/24/2008 | WO2008155059A2 Hydrocarbon mixtures and use thereof |
| 12/24/2008 | WO2008155057A2 Hydrocarbon mixture and use thereof |
| 12/24/2008 | WO2008155035A2 Oxazolidinones for the treatment and prophylaxis of sepsis |
| 12/24/2008 | WO2008155034A1 Substituted oxazolidinones and the use thereof |
| 12/24/2008 | WO2008155033A1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation |
| 12/24/2008 | WO2008155032A1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation |
| 12/24/2008 | WO2008155017A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases |
| 12/24/2008 | WO2008155016A1 Substituted furopyrimidines and use thereof |
| 12/24/2008 | WO2008155001A1 Indazolamide derivatives |
| 12/24/2008 | WO2008155000A1 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives |
| 12/24/2008 | WO2008154905A2 Modifications of the histone deacetylase inhibitor suberoylanilide hydroxamic acid |
| 12/24/2008 | WO2008154900A1 Pharmaceutical composition having a trihydroxy-chromenone derivative |
| 12/24/2008 | WO2008154898A2 Preparation for the treatment of equine laminitis |
| 12/24/2008 | WO2008154820A1 Carbethoxy-substituted thiazolyl dihydropyrimidines |
| 12/24/2008 | WO2008154819A1 Carbethoxy-substituted thiazolyl dihydropyrimidines |
| 12/24/2008 | WO2008154818A1 Fluorophenyl-substituted thiazolyl dihydropyrimidines |
| 12/24/2008 | WO2008154817A1 Bromo-phenyl substituted thiazolyl dihydropyrimidines |
| 12/24/2008 | WO2008154795A1 Use of sanchiosides for treating septicemia |
| 12/24/2008 | WO2008154705A1 Transdermal delivery of active agents |
| 12/24/2008 | WO2008136037A3 Chemical-catalytic method for the peracylation of oleuropein and its products of hydrolysis |
| 12/24/2008 | WO2008136034A3 Ophthalmic compositions for the treatment of ocular hypertension and glaucoma |
| 12/24/2008 | WO2008135674A3 Ibuprofen, cyclodextrines and ternary agent complexes, and pharmaceutical uses thereof |
| 12/24/2008 | WO2008135639A3 Novel useful inhibitors |
| 12/24/2008 | WO2008134618A3 Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders |
| 12/24/2008 | WO2008133937A3 Compositions of tolperisone |
| 12/24/2008 | WO2008133753A3 Anti-viral compounds |
| 12/24/2008 | WO2008133704A3 Antimicrobial and antiviral compounds and methods for their use |
| 12/24/2008 | WO2008131368A3 Styrenyl derivative compounds for treating ophthalmic diseases and disorders |
| 12/24/2008 | WO2008131006A3 Method for inhibiting scavenger receptor-a and increasing immune response to antigens |
| 12/24/2008 | WO2008129529A3 Cannabinoid for the treatment of neuronal damage in diabetic patients |
| 12/24/2008 | WO2008127734A3 Lysine-specific demethylase inhibitors |
| 12/24/2008 | WO2008125839A3 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase |
| 12/24/2008 | WO2008124698A3 Methods of use of gamma inhibitor compounds for the attenuation of pain |
| 12/24/2008 | WO2008124524A3 Aryl sulfonamide compounds as modulators of the cck2 receptor |
| 12/24/2008 | WO2008124097A3 Salts of isophosphoramide mustard and analogs thereof |
| 12/24/2008 | WO2008122967A3 An oral pharmaceutical composition |
| 12/24/2008 | WO2008122966A3 A pharmaceutical composition of tacrolimus |
| 12/24/2008 | WO2008122965A3 Pharmaceutical cyclosporin compositions |
| 12/24/2008 | WO2008121261A3 Prodrugs of triciribin suitable for treatment of tumors and cancer |
| 12/24/2008 | WO2008118785A3 Methods for treating depression using immediate-impact treatments and d-cycloserine |
| 12/24/2008 | WO2008118141A3 Use of cannabinoid modulating compounds in combination with other therapeutic compounds for adjunctive therapy |
| 12/24/2008 | WO2008115999A8 Biaryl and biheteroaryl compounds useful in treating iron disorders |
| 12/24/2008 | WO2008115390A3 Methods of using defensins to treat diabetes |
| 12/24/2008 | WO2008115262A3 Hsp90 inhibitors containing a zinc binding moiety |
| 12/24/2008 | WO2008114800A3 Solid preparation comprising 2- [ [6- [ (3r) -3-amino-1-piperidinyl] -3, 4-dihydro-3-methyl-2, 4-dioxo-1 (2h) -pyrimidinyl] methyl] -4-fluorobenzonitrile |
| 12/24/2008 | WO2008109547A9 Nucleic acid compounds for inhibiting tymp gene expression and uses thereof |
| 12/24/2008 | WO2008109462A3 Sustained release pellets comprising wax-like material |
| 12/24/2008 | WO2008107896A3 Method for growing photosynthetic organisms |
| 12/24/2008 | WO2008107543A3 Derivatives of pyrrolopyridine-2-carboxamids, preparation thereof and therapeutic application thereof |
| 12/24/2008 | WO2008107481A8 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| 12/24/2008 | WO2008104597A3 Sulfonyltryptophanols |
| 12/24/2008 | WO2008103135A3 The micrornaome |
| 12/24/2008 | WO2008100447A3 Nucleoside analogs for antiviral treatment |
| 12/24/2008 | WO2008100240A3 Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same |
| 12/24/2008 | WO2008098178A3 Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 12/24/2008 | WO2008098027A3 Treatment of ischemic retinal conditions with memantine |
| 12/24/2008 | WO2008089436A3 Crystalline forms of histone deacetylase inhibitors |
| 12/24/2008 | WO2008088820A3 Glutamate receptor antagonists and methods of use |
| 12/24/2008 | WO2008086807A3 Mediated cellular delivery of lna oligonucleotides |
| 12/24/2008 | WO2008086269A3 6-aminoisoquinoline compounds useful as kinase modulators |
| 12/24/2008 | WO2008086014A3 Bis-aryl amide derivatives useful for the treatment of cancer |